Substance Withdrawal Syndrome Clinical Trial
Official title:
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
The purpose of this study is to see whether adults who use e-cigarettes every day experience symptoms of nicotine withdrawal when they stop using e-cigarettes for 6 days.
Study Design: The investigators will recruit 120 individuals who are long-term daily and
exclusive users of nicotine-containing e-cigarettes. Participants will be asked to use their
own e-cigarette as usual during the first week of the study and to then stop their use of
e-cigarettes for 6 days. The total study duration will be 14 days. Participants will be
instructed to continue abstinence from other tobacco and nicotine products during the entire
study. The investigators will use an escalating payment system with bonuses based on breath
and urine samples to encourage compliance.
Every day during the study, participants will report e-cigarette and tobacco cigarette use
and monitor symptoms of nicotine withdrawal via a phone call to an Interactive Voice Response
system. Participants will attend 3 study visits each week to provide urine and breath samples
to verify compliance, and to complete brief surveys.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00114439 -
Lithium Cannabis Withdrawal Study
|
Phase 2 | |
Completed |
NCT00980044 -
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
|
Phase 2/Phase 3 | |
Completed |
NCT02643355 -
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
|
N/A | |
Completed |
NCT02782156 -
Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENT
|
N/A | |
Recruiting |
NCT00792415 -
Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool
|
N/A | |
Completed |
NCT02431728 -
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
|
Phase 1/Phase 2 | |
Completed |
NCT00695864 -
Effect of Ondansetron for Withdrawal Symptoms
|
N/A | |
Active, not recruiting |
NCT02951793 -
Abuse and Addiction in ICU
|
||
Completed |
NCT02108626 -
Electronic Cigarettes in Daily Dependent Smokers
|
Phase 4 | |
Recruiting |
NCT04917185 -
EA for PAAS: A pRCT
|
N/A | |
Completed |
NCT02801357 -
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
|
Phase 1 | |
Completed |
NCT01362959 -
Nicotine Replacement Therapy in the Intensive Care Unit
|
Phase 4 | |
Completed |
NCT00992979 -
Therapeutic Massage to Manage Withdrawal Related Anxiety
|
Phase 2 | |
Completed |
NCT00900900 -
The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers
|
Phase 2 | |
Completed |
NCT02318290 -
Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study
|
N/A | |
Completed |
NCT00032968 -
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
|
Phase 3 | |
Completed |
NCT03374722 -
Opioid Withdrawal Symptoms in Critically Ill Patients
|
||
Completed |
NCT03435614 -
Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults
|
||
Completed |
NCT00570219 -
The Effect of Valproate on Benzodiazepine Withdrawal Severity
|
N/A | |
Completed |
NCT00367874 -
Treatment of Polydrug-Using Opiate Dependents During Withdrawal
|
Phase 4 |